Amyloidosis Research Consortium Inc

Medical research organization based in Newton, MA. 20 employees. Exempt under §501(c)(3).

MissionACCELERATING THE DEVELOPMENT OF ADVANCED DIAGNOSTIC TOOLS AND EFFECTIVE TREATMENTS FOR SYSTEMIC AMYLOIDOSIS THROUGH COLLABORATION AND INNOVATION.

Financial snapshot · TY 2024

$3.4M
Total revenue
$3.0M
Total expenses
$4.7M
Net assets

Financial health · TY 2024

51
Moderate financial health
Composite score out of 100 based on reserve ratio, program efficiency, and revenue diversification.
Reserve ratio
53
9.5 months of expenses
Program efficiency
70
78% spent on programs
Revenue diversity
8
Mix of program fees, grants & contributions

Leadership compensation

Isabelle Lousada
PRESIDENT/CEO & CLERK
$175,000
47th percentile vs. peers

Is this your organization?

Claim this page for a private dashboard with financial health, peer benchmarks, and comp history.

Claim this page
Amyloidosis Research Consortium Inc Executive Compensation | 990 Data | DoubleNine